Skip to main content
. 2019 May 21;9:7635. doi: 10.1038/s41598-019-44129-y

Figure 2.

Figure 2

Project development workflow. The full dataset of peptidomics profiles of BC patients (n = 98) was split into training (n = 48) used for model development and test set (n = 50) retained for validation. Feature selection was performed through Cox regression analysis (10 resampling permutations) with 36 peptides found significantly predictive of the relapse (p-value < 0.1). Those were further used in the development of Random Forest-based predictive model of BC relapse. Performance of the model was evaluated on the test set and further optimized.